Topic

New Jersey

A collection of 46 issues

Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey Eligibility: Cigna requires prior authorization for Vitrakvi (larotrectinib) with documented NTRK gene fusion, unresectable/metastatic solid tumors, and oncologist prescribing. Fastest path: Submit PA request via CoverMyMeds portal with NTRK fusion test results, prior therapy documentation, and medical necessity
7 min read

How to Get Orladeyo (Berotralstat) Covered by UnitedHealthcare in New Jersey: Complete Guide with Forms and Appeal Templates

Answer Box: Getting Orladeyo Covered by UnitedHealthcare in New Jersey Orladeyo (berotralstat) requires prior authorization from UnitedHealthcare in New Jersey. To get approved: 1. Visit an HAE specialist (allergist/immunologist) who can document your hereditary angioedema diagnosis with C1-INH testing and attack frequency 2. Submit prior authorization through the UnitedHealthcare
6 min read

Work With Your Doctor to Get Lutathera (Lutetium Lu-177 Dotatate) Approved by Blue Cross Blue Shield in New Jersey

Getting Lutathera Covered: Your Path to Approval Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Blue Cross Blue Shield in New Jersey. Success depends on documenting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), progression on first-line somatostatin analog therapy, and meeting specific medical necessity criteria. The fastest path: work closely with
5 min read